Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-011111
Filing Date
2022-11-07
Accepted
2022-11-07 16:07:49
Documents
2
Period of Report
2022-11-03

Document Format Files

Seq Description Document Type Size
1 form4-11072022_091137.html 4  
1 form4-11072022_091137.xml 4 3640
2 ex24-11072022_091138.htm EX-24 7947
  Complete submission text file 0001415889-22-011111.txt   12923
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address BLUEPRINT MEDICINES CORPORATION 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address
Haviland Kate (Reporting) CIK: 0001663022 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37359 | Film No.: 221365459